Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Five Stocks To Buy: Dixon Tech, Belrise Industries, Marksans Pharma And More | June 10, 2026
Top picks include blue-chip electronics manufacturers, expanding auto components players, mid-tier pharma exporters, and major private and public sector banking stocks.
Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition
Marksans Pharma said it has signed a definitive agreement to acquire 100% of QliniQ's share capital. The acquisition is expected to bolster the company's forward-integration strategy by providing direct sales, marketing and distribution capabilities in the European Union.
Marksans Pharma soars after Q4 PAT jumps 64% YoY
Marksans Pharma surged 13.13% to Rs 249.19 after the company reported strong growth in quarterly earnings.
Marksans Pharma Q4 Results: Stock jumps 12% after profit surges, margin expands
Marksans Pharma also said the impact of the revised Labour Codes relating to employee benefits resulted in a one-time charge of ₹26.1 million during FY26, which has been recognised in employee benefits expense.
Buzzing Stocks: PNC Infra, IndiGo, Wockhardt rally; Inox Wind slips on weak Q4 results
Marksans Pharma shares edged down after the company signed a definitive agreement to acquire 100 percent of the share capital of QliniQ B.V.,.